TSX News -
Trillium Therapeutics to Present at Upcoming Scientific Conferences
TORONTO, ONTARIO–(Marketwired – Nov. 6, 2017) – Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TRIL) a clinical stage immuno-oncology company developing innovative therapies for [...]